A comprehensive approach for drug safety assessment

Chemico-Biological Interactions

Volumn 150, Issue 1, 2004, Pages 27-33

  Li, Albert P ^a  

^a Advanced Pharmaceutical Sciences   (United States)

Author keywords

Drug development; Drug metabolism; Drug safety; Drug toxicity; Paracelsus; Risk factors; Safety assessment

Indexed keywords

ANTINEOPLASTIC AGENT; INFLIXIMAB; NITRATE; NITRITE; PIOGLITAZONE; ROSIGLITAZONE; SILDENAFIL;

ACCURACY; BIOACCUMULATION; CELL CULTURE; CORONARY ARTERY BLOOD FLOW; CROHN DISEASE; DETOXIFICATION; DRUG APPROVAL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG SAFETY; ENVIRONMENTAL FACTOR; EVALUATION; HEART INFARCTION; HEREDITY; HUMAN; HYPOTENSION; IN VIVO STUDY; PARAMETER; PHARMACOPHORE; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; SIDE EFFECT;

ANIMALIA;

EID: 7444258439     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2004.09.009     Document Type: Article

References (20)

1. J.F. Borzelleca Paracelsus: herald of modern toxicology Toxicol. Sci. 2000 53
2. Centocor Dear Health Professional Letter, October 5, 2001.
3. Pfizer Dear Doctor Letter, May 1998.
4. Ultra Health Laboratories, Inc. Press Release, April 4, 2003.
5. EM. Hulzebos, and R. Posthumus (Q)SARs: gatekeepers against risk on chemicals? SAR QSAR Environ. Res. 14 2003 285 316
6. D. Zmuidinavicius, P. Japertas, A. Petrauskas, and R. Didziapetris Progress in toxinformatics: the challenge of predicting acute toxicity Curr. Top. Med. Chem. 3 2003 1301 1314
7. J.T. MacGregor, J.M. Collins, Y. Sugiyama, C.A. Tyson, J. Dean, L. Smith, M. Andersen, R.D. Curren, J.B. Houston, F.F. Kadlubar, G.L. Kedderis, K. Krishnan, A.P. Li, R.E. Parchment, K. Thummel, J.E. Tomaszewski, R. Ulrich, A.E. Vickers, and S.A. Wrighton In vitro human tissue models in risk assessment: report of a consensus-building workshop Toxicol. Sci. 59 2001 17 36
8. A.P. Li Screening for human ADME/Tox drug properties in drug discovery Drug Discov. Today 6 2002 357 366
9. A.P. Li A review of the common properties of drugs with idiosyncratic hepatotoxicity and the "multiple determinant hypothesis" for the manifestation of idiosyncratic drug toxicity Chem. Biol. Interact. 142 2002 7 23
10. U.A. Oelsterli, H.J. Zimmerman, and A. Kretz-Rommel Idiosyncratic liver toxicity of nonsteroidal antiinflammatory drugs: molecular mechanisms and pathology Crit. Rev. Toxicol. 25 1995 207 235
11. D.P. Williams, and B.K. Park Idiosyncratic toxicity: the role of toxicophores and bioactivation Drug Discov. Today 8 2003 1044 1050
12. J. Uetrecht N-oxidation of drugs associated with idiosyncratic drug reactions Drug Metab. Rev. 34 2002 651 665
13. C. Schleger, S.J. Platz, and U. Deschl Development of an in vitro model for vascular injury with human endothelial cells ALTEX 21 Suppl. 3 2004 12 29
14. A.P. Li, C. Lu, J.A. Brent, C. Pham, A. Fackett, C.E. Ruegg, and P.M. Silber Cryopreserved human hepatocytes: characterization of drug-metabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential Chem. Biol. Interact. 121 1999 17 35
15. W. Li, D.F. Choy, M.S. Lam, T. Morgan, M.E. Sullivan, and J.M. Post Use of cultured cells of kidney origin to assess specific cytotoxic effects of nephrotoxins Toxicol. In Vitro 17 2003 107 113
16. A.P. Li, A novel cell culture tool, U.S.P.T.O. Application Number 10/751983 (2004).
17. L.D. Kier, R. Neft, L. Tang, R. Suizu, T. Cook, K. Onsurez, K. Tiegler, Y. Sakai, M. Ortiz, T. Nolan, U. Sankar, and A.P. Li Applications of microarrays with toxicologically-relevant genes (tox genes) for the evaluation of chemical toxicants in Sprague Dawley rats in vivo and human hepatocytes in vitro Mutat. Res. 549 2004 101 113
18. F.V. Schiodt, W.M. Lee, S. Bondesen, P. Ott, and E. Christensen Influence of acute and chronic alcohol intake on the clinical course and outcome in acetaminophen overdose Aliment. Pharmacol. Ther. 16 2002 707 715
19. U.A. Boelsterli Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity Toxicol. Appl. Pharmacol. 192 2003 307 322
20. R.A. Roth, J.P. Luyendyk, J.F. Maddox, and P.E. Ganey Inflammation and drug idiosyncrasy - is there a connection? J. Pharmacol. Exp. Ther. 307 2003 1 8